CN1292702A - 新型避孕药盒 - Google Patents

新型避孕药盒 Download PDF

Info

Publication number
CN1292702A
CN1292702A CN998037710A CN99803771A CN1292702A CN 1292702 A CN1292702 A CN 1292702A CN 998037710 A CN998037710 A CN 998037710A CN 99803771 A CN99803771 A CN 99803771A CN 1292702 A CN1292702 A CN 1292702A
Authority
CN
China
Prior art keywords
contraceptive
steroid
structural formula
pharmaceutically acceptable
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN998037710A
Other languages
English (en)
Chinese (zh)
Inventor
H·J·克路斯特泊尔
G·H·J·德克斯
J·A·M·哈莫斯马
P·M·威伯斯特
H·J·T·科林格本尼克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of CN1292702A publication Critical patent/CN1292702A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
CN998037710A 1998-03-09 1999-03-03 新型避孕药盒 Pending CN1292702A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98200744 1998-03-09
EP98200744.5 1998-03-09

Publications (1)

Publication Number Publication Date
CN1292702A true CN1292702A (zh) 2001-04-25

Family

ID=8233452

Family Applications (1)

Application Number Title Priority Date Filing Date
CN998037710A Pending CN1292702A (zh) 1998-03-09 1999-03-03 新型避孕药盒

Country Status (20)

Country Link
EP (1) EP1061928A2 (fr)
JP (1) JP2002506014A (fr)
KR (1) KR20010041698A (fr)
CN (1) CN1292702A (fr)
AR (1) AR018313A1 (fr)
AU (1) AU756882B2 (fr)
BR (1) BR9908605A (fr)
CA (1) CA2319765A1 (fr)
CO (1) CO5070598A1 (fr)
HU (1) HUP0101007A3 (fr)
ID (1) ID25621A (fr)
IL (1) IL137541A0 (fr)
NO (1) NO20004492L (fr)
NZ (1) NZ506115A (fr)
PE (1) PE20000330A1 (fr)
PL (1) PL343428A1 (fr)
RU (1) RU2225714C2 (fr)
TR (1) TR200002593T2 (fr)
WO (1) WO1999045886A2 (fr)
ZA (1) ZA991851B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4134599A (en) * 1998-04-07 1999-10-25 Akzo Nobel N.V. Progestogen-only contraceptive kit
NZ517281A (en) * 1999-09-06 2003-09-26 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11
US7696190B2 (en) 2000-07-28 2010-04-13 N.V. Organon 16Alpha-methyl or ethyl substituted estrogens
US20030225048A1 (en) * 2002-03-11 2003-12-04 Caubel Patrick Michel Sulfatase inhibiting continuous progestogen contraceptive regimens
CN1652799A (zh) * 2002-03-11 2005-08-10 詹森药业有限公司 只用抑制硫酸酯酶的孕激素的避孕给药方案
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints

Also Published As

Publication number Publication date
ID25621A (id) 2000-10-19
ZA991851B (en) 1999-09-22
EP1061928A2 (fr) 2000-12-27
CO5070598A1 (es) 2001-08-28
WO1999045886A3 (fr) 1999-12-02
BR9908605A (pt) 2001-04-24
AR018313A1 (es) 2001-11-14
CA2319765A1 (fr) 1999-09-16
NZ506115A (en) 2003-07-25
NO20004492D0 (no) 2000-09-08
AU756882B2 (en) 2003-01-23
WO1999045886A2 (fr) 1999-09-16
NO20004492L (no) 2000-09-08
PE20000330A1 (es) 2000-05-16
AU3143799A (en) 1999-09-27
KR20010041698A (ko) 2001-05-25
TR200002593T2 (tr) 2000-12-21
HUP0101007A3 (en) 2002-02-28
PL343428A1 (en) 2001-08-13
HUP0101007A2 (hu) 2001-12-28
IL137541A0 (en) 2001-07-24
JP2002506014A (ja) 2002-02-26
RU2225714C2 (ru) 2004-03-20

Similar Documents

Publication Publication Date Title
EP1272505B1 (fr) Derives de 11beta-pentyle- et 11beta-hexyl-estra-1,3,5(10)-triene substitues en position 8beta
JP4368945B2 (ja) 新規１９―ノループレグネン誘導体類
JP3814292B2 (ja) エストラ−１，３，５（１０）−トリエン誘導体、これらの製造方法及びこれら化合物を含有する製薬組成物
CN1125077C (zh) 1,3,5(10)－雌三烯的氨基磺酸酯衍生物、其制备方法和含有这些化合物的药物
CA2358466C (fr) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroides et leurs derives presentant des proprietes hormonales agonistes ou antagonistes
US4027019A (en) 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
CN1052237C (zh) 具有17-螺亚甲基内酯或邻位羟基内醚基的甾族化合物
US3159543A (en) 3-cyclopentyl and cyclopentenyl ethers of estrone and derivatives thereof
CA2384184C (fr) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl-steroides et leurs derives presentant des proprietes hormonales antagonistes
AU756882B2 (en) New contraceptive kit
CN100354299C (zh) 在11位带有烃取代基的非芳香族雌激素甾族化合物
IE872217L (en) 14,17-beta-ethano-14-beta-estratrienes and estratetraenes
CN1281363A (zh) 孕激素-抗孕激素体系
US3764596A (en) 17-dihydrofuranyl-substituted steroids
US7696190B2 (en) 16Alpha-methyl or ethyl substituted estrogens
JP2007210994A (ja) ステロイド類、それらの調製、それらの薬学的組成物およびこの化合物の使用
MXPA00008814A (en) New contraceptive kit
US3912768A (en) Norethindrone O-alkyloximes
AU2001282016A1 (en) 16alpha-methyl or ethyl substituted estrogens
CZ20003285A3 (cs) Antikoncepční sada
US3661940A (en) Derivatives of 21-methyl-19-norpregnanes
KR20100094999A (ko) １５,１６-메틸렌-１７-히드록시-１９-노르-２１-카르복실산 γ-락톤 유도체, 그의 용도 및 상기 유도체를 함유하는 의약
KR100940054B1 (ko) 호르몬 효과를 갖는 17알파-히드록시-14베타-스테로이드
DE19649984A1 (de) Cycloalkylsteroide, Verfahren zu ihrer Herstellung, diese Cycloalkylsteroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE1966504A1 (de) Oral wirksames konzeptionsverhinderndes mittel

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication